Critical Care Diagnostics, Inc. (USA)

The company Critical Care Diagnostics, Inc. (USA) was founded in 2004.  The main product of the company are the analyzer and ELISA test for the innovative marker of heart failure ST2, discovered in 2002, and for which the Critical Diagnostics has exclusive rights. At the moment the company has expanded its intellectual property portfolio and has several patents in the US and other countries, and, many patents are pending.

Web site of the company: